These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2676252)

  • 21. Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Mancia G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-3. PubMed ID: 1725194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases.
    Lüscher TF; Wenzel RR; Moreau P; Takase H
    Cardiovasc Drugs Ther; 1995 Aug; 9 Suppl 3():509-23. PubMed ID: 8562468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
    Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN
    Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Do converting enzyme inhibitors differ from each other in the treatment of hypertension?].
    Laurent S; Billaud E; Kreft-Jais C
    Rev Prat; 1992 Dec; 42(20):2533-7. PubMed ID: 1299936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
    Weber MA
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
    DiBianco R
    Postgrad Med; 1985 Oct; 78(5):229-41, 244, 247-8. PubMed ID: 2864682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ACE-I for patients with hypertension].
    Hatta T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():318-21. PubMed ID: 16981561
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ACE inhibitors in the treatment of hypertension in elderly patients].
    Evéquoz D; Reichenstein T; Waeber B; Nussberger J; Brunner HR
    Schweiz Rundsch Med Prax; 1991 Jun; 80(25):701-6. PubMed ID: 1857901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE inhibitors. A safe option for hypertension and congestive heart failure.
    Amadio P; Amadio PB; Cummings DM
    Postgrad Med; 1990 Jan; 87(1):223-6, 231-2, 235-43. PubMed ID: 2404266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin converting enzyme inhibitors for hypertension].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 1997 Jan; 2(7):66-70. PubMed ID: 9296907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II-receptor blockers: clinical relevance and therapeutic role.
    Rodgers JE; Patterson JH
    Am J Health Syst Pharm; 2001 Apr; 58(8):671-83. PubMed ID: 11329759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH
    Z Kardiol; 1988; 77 Suppl 3():69-71. PubMed ID: 2850690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue ACE inhibition and organ protection.
    Dal Palù C
    Clin Physiol Biochem; 1992; 9(3):87-8. PubMed ID: 1302162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.